Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | APAF1 | O14727 | 1/20 | 0.42 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.41 |
| ▸ | PGR | P06401 | 2/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7506974 | 1.00 | ALOX15 (0.47) | ALOX15KDM4EMAPTHSD11B1MEN1 | |
| SCHEMBL7506984 | 1.00 | ALOX15 (0.47) | ALOX15KDM4EMAPTHSD11B1MEN1 | |
| SCHEMBL9140727 | 0.90 | KDM4E (0.45) | ALOX15KDM4EMAPTHSD11B1MEN1 | |
| SCHEMBL9138286 | 0.87 | ALDH1A1 (0.50) | ALOX15KDM4EMAPTHSD11B1MEN1 | |
| SCHEMBL9139185 | 0.84 | KDM4E (0.45) | ALOX15KDM4EMAPTHSD11B1MEN1 | |
| SCHEMBL9139749 | 0.84 | ELANE (0.46) | ALOX15KDM4EMAPTHSD11B1MEN1 | |
| SCHEMBL9145406 | 0.80 | KDM4E (0.42) | ALOX15KDM4EMAPTHSD11B1MEN1 | |
| SCHEMBL8612575 | 0.80 | KDM4E (0.42) | ALOX15KDM4EMAPTHSD11B1MEN1 | |
| SCHEMBL7505033 | 0.79 | KDM4E (0.41) | ALOX15KDM4EMAPTHSD11B1MEN1 | |
| SCHEMBL7511055 | 0.78 | PGR (0.47) | ALOX15KDM4EMAPTHSD11B1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0731091-B1 | 2-OXOINDOLINE DERIVATIVES AS CHOLECYSTOKININ RECEPTOR ANTAGONISTS | TANABE SEIYAKU CO (JP) | 2002-01-02 | — | — | EP | disclosed |
| US-5807883-A | GASTROINTESTINAL DISORDERS; PANCREATITIS | TANABE SEIYAKU CO., LTD. (JP) | 1998-09-15 | — | — | US | disclosed |
| EP-0731091-A1 | 2-OXOINDOLINE DERIVATIVE | TANABE SEIYAKU CO., LTD. (JP) | 1996-09-11 | — | — | EP | disclosed |
| US-5434148-A | β-carboline derivative | TANABE SEIYAKU CO., LTD. (JP) | 1995-07-18 | — | — | US | disclosed |
| EP-0572235-A2 | Beta-carboline derivatives with anticholecystoquinine activity | TANABE SEIYAKU CO., LTD. (JP) | 1993-12-01 | — | — | EP | disclosed |